Skip to Main Content

Author Details

Richard L Sidman
Harvard Medical School
1951
264
81
PMIDPaper TitleJournal TitlePublished Year
35027678Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats.Mol Psychiatry2022
33323946Does the RAAS play a role in loss of taste and smell during COVID-19 infections?Pharmacogenomics J2021
33870243Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates.Med2021
33758865Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.bioRxiv2021
33503971A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases.Cancers (Basel)2021
33751590Amphibian regeneration and mammalian cancer: Similarities and contrasts from an evolutionary biology perspective: Comparing the regenerative potential of mammalian embryos and urodeles to develop effective strategies against human cancer.Bioessays2021
34749885Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling.Elife2021
34060472Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer.Elife2021
34234013Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.Proc Natl Acad Sci U S A2021
34330827Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia.Proc Natl Acad Sci U S A2021
31130731Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.Cancer Gene Ther2020
33219123Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migration.Proc Natl Acad Sci U S A2020
33004692Nna1 gene deficiency triggers Purkinje neuron death by tubulin hyperglutamylation and ER dysfunction.JCI Insight2020
32402283A Biomarker for Predicting Responsiveness to Stem Cell Therapy Based on Mechanism-of-Action: Evidence from Cerebral Injury.Cell Rep2020
30476961Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease: A Review.JAMA Neurol2019
31375630Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer.Proc Natl Acad Sci U S A2019
30670660A ligand motif enables differential vascular targeting of endothelial junctions between brain and retina.Proc Natl Acad Sci U S A2019
29205207Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.Pharmacogenomics J2018
30209664Modeling Complex Neurological Diseases with Stem Cells: A Study of Bipolar Disorder.Results Probl Cell Differ2018
29720567Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications.JCI Insight2018
29490919MLH1-rheMac hereditary nonpolyposis colorectal cancer syndrome in rhesus macaques.Proc Natl Acad Sci U S A2018
28652618Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting.Sci Rep2017
28223512Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.Proc Natl Acad Sci U S A2017
28102462Cerebellar Pathways in Mouse Model of Purkinje Cell Degeneration Detected by High-Angular Resolution Diffusion Imaging Tractography.Cerebellum2017
28428279Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.Cancer Res2017
28096400Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation.Proc Natl Acad Sci U S A2017
28500272Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.Proc Natl Acad Sci U S A2017
28751581Going viral? Linking the etiology of human prostate cancer to the <i>PCA3</i> long noncoding RNA and oncogenic viruses.EMBO Mol Med2017
28698375BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation.Proc Natl Acad Sci U S A2017
28548103An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.Cancer Gene Ther2017
26839407Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.Proc Natl Acad Sci U S A2016
26671631Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.Neurosurgery2016
27791181Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.Proc Natl Acad Sci U S A2016
27791177Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.Proc Natl Acad Sci U S A2016
27189170Brain endothelial cell-targeted gene therapy of neurovascular disorders.EMBO Mol Med2016
27317903Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.Am J Pathol2016
26912667Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes.Mol Cell Proteomics2016
26858439Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors.Proc Natl Acad Sci U S A2016
26884209AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.Proc Natl Acad Sci U S A2016
26772878Ligand-targeted theranostic nanomedicines against cancer.J Control Release2016
25775553Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch.Proc Natl Acad Sci U S A2015
26468327The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.Sci Transl Med2015
26056266Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.Proc Natl Acad Sci U S A2015
26080435PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.Proc Natl Acad Sci U S A2015
25659743Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis.Proc Natl Acad Sci U S A2015
25675522Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer.Proc Natl Acad Sci U S A2015
25623065Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer.J Biol Chem2015
25640897Ligand-directed profiling of organelles with internalizing phage libraries.Curr Protoc Protein Sci2015
25762070Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.Proc Natl Acad Sci U S A2015
24496871Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia.Cancer2014
  • 1 - 50 of 264

Recommended Authors

Cavanilles Institute, University of Valencia
Career Start Year 2006
Number of shared co-authors 0
Johns Hopkins University School of Medicine.
Career Start Year 1994
Number of shared co-authors 1
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 1993
Number of shared co-authors 0
University of California san francisco
Career Start Year 1990
Number of shared co-authors 1
University of California, University of California Irvine
Career Start Year 1989
Number of shared co-authors 3
UCL Queen Square Institute of Neurology
Career Start Year 1989
Number of shared co-authors 1
National Institute of Neurological Disorders and Stroke
Career Start Year 1986
Number of shared co-authors 1
university of california san diego School of Medicine, University of California
Career Start Year 1986
Number of shared co-authors 2
the Francis Crick Institute
Career Start Year 1986
Number of shared co-authors 2
National Institute of Mental Health
Career Start Year 1986
Number of shared co-authors 0
Institute of Developmental Genetics, German Research Center for Environmental Health
Career Start Year 1984
Number of shared co-authors 1
Wellcome Trust-Medical Research Council Stem Cell Institute and.
Career Start Year 1983
Number of shared co-authors 4
Cavanilles Institute, University of Valencia
Career Start Year 1981
Number of shared co-authors 0
Howard Hughes Medical Institute, Harvard Medical School
Career Start Year 1981
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1981
Number of shared co-authors 5
Howard Hughes Medical Institute, The Rockefeller University
Career Start Year 1980
Number of shared co-authors 1
Northern Clinical School, Sydney Medical School, University of Sydney
Career Start Year 1980
Number of shared co-authors 0
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1980
Number of shared co-authors 0
Salk Institute for Biological Studies
Career Start Year 1980
Number of shared co-authors 1
University of Toronto
Career Start Year 1977
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 1977
Number of shared co-authors 1
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1975
Number of shared co-authors 0
university of california san diego
Career Start Year 1975
Number of shared co-authors 1
University of California san francisco
Career Start Year 1974
Number of shared co-authors 0
National Center for Microscopy and Imaging Research, University of California
Career Start Year 1974
Number of shared co-authors 3
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 4
University of California San Diego
Career Start Year 1973
Number of shared co-authors 2
University of British Columbia
Career Start Year 1972
Number of shared co-authors 1
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1965
Number of shared co-authors 2
Institut de la Vision, Sorbonne Universite, INSERM, CNRS
Career Start Year 1959
Number of shared co-authors 1

Collaborators

Rutgers Cancer Institute of New Jersey
Co-authored papers 63
Rutgers Cancer Institute of New Jersey
Co-authored papers 62
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 30
Rutgers Cancer Institute of New Jersey
Co-authored papers 21
Karmanos Cancer Institute (KCI), Wayne State University
Co-authored papers 16
Institute of Chemistry, University of Sao Paulo
Co-authored papers 11
A.C. Camargo Cancer Center
Co-authored papers 8
Stanford University School of Medicine
Co-authored papers 7
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 7
A.C. Camargo Cancer Center
Co-authored papers 7
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 6
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 6
Center for Phenomic Health, The Buck Institute for Research on Aging
Co-authored papers 5
The Rockefeller University
Co-authored papers 4
The State University of New Jersey
Co-authored papers 3
Houston Methodist Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
MD Anderson Cancer Center
Co-authored papers 3
Chemistry Institute, Universidade de Sao Paulo - USP
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Spaulding Rehabilitation Hospital, Harvard Medical School
Co-authored papers 2
Harvard Medical School and McLean Hospital
Co-authored papers 2
Co-authored papers 2
Georgia Cancer Center
Co-authored papers 2
Weill Cornell School of Medicine
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
University of New Mexico School of Medicine
Co-authored papers 2
The Ohio State University Wexner Medical Center
Co-authored papers 2
Co-authored papers 2